•  •  Dark Mode

Your Interests & Preferences

I am a...

law firm lawyer
in-house company lawyer
litigation lawyer
law student
aspiring student
other

Website Look & Feel

 •  •  Dark Mode
Blog Layout

Save preferences
Subscribe for perks & to support LI

2018’s 50 busiest Supreme Court AOR law firms • Khaitan leads in Big 7 with 213 filings • JSA, SAM also 100+

113 people have already read this article, which will unlock for non-subscribers like you in . So what are you waiting for? Subscribe now!

NUJS IP chair prof Shamnad Basheer intervenes in ‘epic’ SC Novartis case, ‘first time in 60 years’

NUJS Kolkata professor Shamnad Basheer, who is the HRD ministry’s chair professor for intellectual property, argued over two days in his first-of-its-kind academic intervention in the landmark Novartis-Glivec patent hearing in the Supreme Court.

Swiss drug maker Novartis had approached the SC in September when it was refused a patent for cancer drug Glivec which is sold by India’s generic drug makers to reportedly 1.2 billion Indians and to poorer nations across the world.

Basheer argued before justices Aftab Alam and Ranjana Desai that even though Novartis didn’t satisfy the test to patent Glivec, excessive pricing can also not be a ground to revoke a patent. [Spicy IP]

In August, pharma company Natco had filed for defamation against Basheer in the Delhi high court, claiming that its reputation was harmed by Basheer’s comments in his entry in SpicyIP on the company’s ongoing legal battle.

Click to show 25 comments
at your own risk
(alt+c)
By reading the comments you agree that they are the (often anonymous) personal views and opinions of readers, which may be biased and unreliable, and for which Legally India therefore has no liability. If you believe a comment is inappropriate, please click 'Report to LI' below the comment and we will review it as soon as practicable.

Latest comments